Department of Anesthesiology and Intensive Care, Assiut University, Asyut, Egypt.
Asyut Urology and Nephrology Hospital, Assiut University, Asyut, Egypt.
Pain Physician. 2019 Mar;22(2):E71-E80.
Intravenous lidocaine infusion (IVLI) reduces postoperative pain and hastens the return of bowel function.
We aimed to compare the effects of adding lidocaine infusion to enhanced recovery pathway (ERP) on acute rehabilitation protocol.
This study uses a double-blind, randomized design with allocation concealment in a 2-armed parallel group format among patients undergoing open radical cystectomy (RC).
The study was conducted at Assiut University Hospital, Asyut, Egypt. The study duration was March 2017 to July 2018.
After ethics committee approval, 111 patients, American Society of Anesthesiologists (ASA) physical status II-III, aged 45-65 years, scheduled for open RC with urinary diversion under an ERP, were randomly selected in a double-blind manner to receive IVLI 2 mg/minute for 4 hours or an equal volume of normal saline solution 0.9%. Postoperative pain scores, rescue analgesic consumption, times to return of bowel sounds, first flatus, first defecation, resuming of regular diet, length of hospital stay, in-hospital complications, and patient satisfaction were recorded.
Patients in the lidocaine group experienced significantly lower pain scores after surgery at 6 hours (P = 0.005) and 12 hours (P = 0.001) at rest, and in the first 18 hours during mobilization (P < 0.05), with less paracetamol (P = 0.04) and meperidine (P = 0.02) consumption than in the control group. Between the lidocaine and the control group, mean times to return of bowel sounds (23.7 vs. 26.7 hours; P = 0.001), first flatus (76.5 vs. 86.5 hours; P = 0.001), first defecation (92.7 vs. 106.9 hours; P = 0.001) and resuming of regular diet (80.7 vs. 92.8 days; P = 0.001) were significantly shorter in the lidocaine group. Length of hospital stay, in-hospital complications, and patient satisfaction were similar in both groups.
Limitations of this study include lack of previous research that compare the additive effects of IVLI to ERP in patients undergoing open RC. Also, the inability to measure the serum lidocaine concentration in our patients.
Adding IVLI to ERP improved postoperative analgesia and bowel function after open RC with urinary diversion.
NCT03047057.
Lidocaine infusion, ileus, enhanced recovery pathway, acute rehabilitation, open radical cystectomy.
静脉注射利多卡因输注(IVLI)可减轻术后疼痛并加快肠道功能恢复。
我们旨在比较在加速康复方案中加入利多卡因输注对急性康复方案的影响。
这是一项采用双盲、随机设计的研究,在接受开放根治性膀胱切除术(RC)的患者中以 2 臂平行组的形式进行分组。
该研究在埃及阿西尤特 Assiut 大学医院进行。研究时间为 2017 年 3 月至 2018 年 7 月。
在获得伦理委员会批准后,111 名美国麻醉医师协会(ASA)身体状况 II-III 级、年龄 45-65 岁的患者,随机以双盲方式选择接受 IVLI 2mg/min 输注 4 小时或等体积生理盐水 0.9%。记录术后疼痛评分、解救性镇痛药物的使用、肠鸣音恢复时间、首次排气、首次排便、恢复常规饮食、住院时间、院内并发症和患者满意度。
利多卡因组患者在术后 6 小时(P = 0.005)和 12 小时(P = 0.001)休息时、在移动时的前 18 小时(P < 0.05)时的疼痛评分明显较低,且使用扑热息痛(P = 0.04)和哌替啶(P = 0.02)的次数更少。与对照组相比,利多卡因组的肠鸣音恢复时间(23.7 与 26.7 小时;P = 0.001)、首次排气时间(76.5 与 86.5 小时;P = 0.001)、首次排便时间(92.7 与 106.9 小时;P = 0.001)和恢复常规饮食时间(80.7 与 92.8 天;P = 0.001)明显缩短。两组患者的住院时间、院内并发症和患者满意度相似。
本研究的局限性在于缺乏比较静脉注射利多卡因对接受开放 RC 与尿流改道的患者加速康复方案的附加影响的先前研究。此外,我们的患者无法测量血清利多卡因浓度。
在加速康复方案中加入 IVLI 可改善开放 RC 与尿流改道术后的镇痛和肠道功能。
NCT03047057。
利多卡因输注,肠梗阻,加速康复方案,急性康复,开放根治性膀胱切除术。